ketoconazole has been researched along with 6-ketoprostaglandin f1 alpha in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, F; Hechtman, HB; Lelcuk, S; Shepro, D; Valeri, CR | 1 |
| Hechtman, HB; Huval, WV; Lelcuk, S; Shepro, D; Valeri, CR | 1 |
| Krambovitis, E; Tsatsakis, AM; Tzanakakis, GN; Vezeridis, MP | 1 |
1 trial(s) available for ketoconazole and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Inhibition of ischemia-induced thromboxane synthesis in man.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Arm; Blood Platelets; Female; Humans; Ischemia; Ketoconazole; Male; Thromboxane A2; Thromboxane B2; Thromboxanes | 1984 |
2 other study(ies) available for ketoconazole and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Thromboxane A2 moderates permeability after limb ischemia.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Capillary Permeability; Dogs; Extremities; Ischemia; Ketoconazole; Thromboxane A2; Thromboxane B2 | 1985 |
The preventive effect of ketoconazole on experimental metastasis from a human pancreatic carcinoma may be related to its effect on prostaglandin synthesis.
Topics: 6-Ketoprostaglandin F1 alpha; Adenocarcinoma; Animals; Antineoplastic Agents; Dinoprostone; Humans; Injections, Intraperitoneal; Ketoconazole; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Metastasis; Pancreatic Neoplasms; Prostaglandin Antagonists; Prostaglandin D2; Prostaglandins; Thromboxane B2; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |